Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis
A technology of dihydrotetrabenazine and multiple sclerosis, applied in the field of multiple sclerosis treatment of dihydrotetrabenazine, can solve the problems such as the use of multiple sclerosis is not disclosed
Inactive Publication Date: 2010-12-29
BIOVAIL LAB INT BARBADOS
View PDF4 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Our application WO 2007 / 017643 discloses the use of 3,11b-cis-dihydrotetrafenazine as an anti-inflammatory agent but not in the treatment of multiple sclerosis
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
example 1
example 2
example 3
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention provides a compound for use in treating multiple sclerosis wherein the compound is a 3, 11b-cis-dihydrotetrabenazine of the formula (Ia): or a pharmaceutically acceptable salt thereof.
Description
The invention relates to the use of dihydrotetrabenazine in treating multiple sclerosis. Background of the invention Multiple sclerosis (MS) is a disabling neurological disorder characterized by the progressive breakdown of myelin, a protective fatty layer that surrounds nerve fibers in the central nervous system. As a result of myelin damage, these nerve fibers can no longer conduct electrical signals effectively and this produces a variety of symptoms, including changes in sensation, visual problems, muscle weakness, depression, difficulties with coordination and speech, severe fatigue, cognitive Impairment, balance problems, overheating, pain, and urinary and fecal incontinence. In more severe cases, MS can cause mobility and disability. MS is generally classified as an autoimmune disease, which results from an individual's immune system attacking the nervous system. Multiple sclerosis can be divided into three types: relapsing-remitting MS, secondary progressive MS, a...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4745A61P25/28
CPCA61K31/4745A61P1/08A61P1/12A61P13/00A61P13/02A61P17/04A61P21/00A61P25/00A61P25/22A61P25/24A61P25/28A61P27/02A61P27/16A61P29/00A61P37/06A61P43/00
Inventor 安德鲁·约翰·达菲尔德
Owner BIOVAIL LAB INT BARBADOS
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com